跳至主要内容
临床试验/NCT02085239
NCT02085239撤回4 期

Comparison of Long Acting vs. Short Acting Anesthetic Agents as a Tool for Improving Pain Management Post Ultrasound Guided Breast Biopsy

TriHealth Inc.1 个研究点 分布在 1 个国家开始时间: 2013年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
撤回
试验地点
1
主要终点
Change in pain level from baseline to 1 hour

研究概览

简要总结

This study will evaluate the potential role of a long acting anesthetic (ropivacaine) in providing an extended period of pain relief for patients undergoing ultrasound guided core biopsy of the breast.

详细描述

The purpose of this study is to evaluate the potential role of a long acting anesthetic (ropivacaine) in providing an extended period of pain relief for patients undergoing ultrasound guided core biopsy of the breast. One group of patients will receive lidocaine alone for local anesthesia. A second group of patients will similarly receive lidocaine prior to tissue sampling, followed by infiltration of the biopsy area with ropivacaine.

Our hypothesis is that patients who receive a long acting anesthetic (ropivacaine) along with the popular short acting anesthetic (lidocaine), will be pain free after the breast biopsy procedure for a longer period of time than the patients who only receive lidocaine (the short acting anesthetic). This will lessen the emotional and physical trauma associated with the procedure and give patients a better experience thereby improving patient care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with breast lesions recommended for biopsy by physician

排除标准

  • Patients with breast lesions not recommended for biopsy
  • Patients with allergic reactions to lidocaine, ropivacaine, or related anesthetics

研究组 & 干预措施

Lidocaine alone

Active Comparator

Lidocaine: 8-10 ml of Lidocaine by subcutaneous injection

干预措施: Lidocaine alone (Drug)

Lidocaine Ropivacaine

Experimental

Lidocaine Ropivacaine

  • 8-10 ml of Lidocaine given by subcutaneous injection
  • 8-10 ml of Ropivacaine given by subcutaneous injection

干预措施: Lidocaine Ropivacaine (Drug)

结局指标

主要结局

Change in pain level from baseline to 1 hour

时间窗: 1 hour after procedure

Amount of pain that patient is feeling at baseline and 1 hour after the procedure

次要结局

  • Change in pain level from 5 to 10 hours after the procedure(10 hours after procedure)
  • Change in pain level from 10 to 24 hours after procedure(24 hours after procedure)
  • Pathology(up to 72 hours after procedure)
  • Change in pain level from 1 hour to 5 hours after procedure(5 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验